More MS news articles for July 2003
views of explicit rationing: what are the implications for health service
J Health Serv Res Policy. 2003 Jun;8(3):183-6
Devlin N, Appleby J, Parkin D.
Department of Economics, City University, London, UK.
Patient groups in England and Wales have expressed concerns about the
decision-making processes of the National Institute for Clinical Excellence
(NICE), the body responsible for explicit rationing.
Five key issues were identified by the Multiple Sclerosis Society regarding
NICE appraisals and guidance:
We question the veracity of some of these arguments and, where appropriate,
suggest ways in which NICE's processes might be strengthened.
they focus too narrowly on costs to the National Health Service;
quality-adjusted life-years are an inadequate measure of health gain, particularly
for long-term conditions;
NICE takes too conservative a view of long-term benefits;
NICE's cost-effectiveness threshold is inappropriate;
and NICE evaluations fail to capture patients' personal experiences of
their condition and treatments.